Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 2/20 | 0.52 |
| ▸ | LIPG | Q9Y5X9 | 9/20 | 0.49 |
| ▸ | LPL | P06858 | 8/20 | 0.49 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.40 |
| ▸ | KDR | P35968 | 2/20 | 0.40 |
| ▸ | P4HB | P07237 | 1/20 | 0.33 |
| ▸ | ALOX5AP | P20292 | 2/20 | 0.32 |
| ▸ | FEN1 | P39748 | 2/20 | 0.32 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.31 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27192699 | 0.91 | DGAT1 (0.55) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL20176546 | 0.90 | DGAT1 (0.56) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL20176703 | 0.87 | LIPG (0.59) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL20176687 | 0.83 | DGAT1 (0.48) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL17539979 | 0.83 | LIPG (0.64) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL30739 | 0.82 | DGAT1 (0.70) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL29688361 | 0.82 | DGAT1 (0.70) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL20176559 | 0.82 | LIPG (0.52) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL18015662 | 0.80 | DGAT1 (0.70) | DGAT1LIPGLPLPDGFRBKDR | |
| SCHEMBL24654364 | 0.79 | LIPG (0.77) | DGAT1LIPGLPLPDGFRBKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11667622-B2 | Organic light emitting compound and organic electroluminescence device using same | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2023-06-06 | — | — | US | disclosed |
| US-11667622-B2 | Organic light emitting compound and organic electroluminescence device using same | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2023-06-06 | — | — | US | disclosed |
| WO-2018093231-A1 | ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME | 주식회사 두산 | 2018-05-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11667622-B2 | Organic light emitting compound and organic electroluminescence device using same | OR10J3, ICMT, SLCO4C1 | DGAT1 281/4885LIPG 812/4885LPL 695/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.